AXSM20270319C250
AXSM Mar 19 2027 250.00 Call (AXSM270319C00250000)
option OPRA

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.